In fact, cancer cells depend
mainly on anaerobic respiration and their glycolytic rate is up to
200 times higher than that of the normal tissue. This fermentative
glycolysis is promoted by an overexpression of several enzymes
and transporters, which may offer rather safe therapeutic windows
for anticancer agents that target them